Endocrinology, Diabetes and Metabolism; Orthopedics and Sports Medicine; Endocrinology
Disciplines :
Laboratory medicine & medical technology
Author, co-author :
Cavalier, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chimie clinique ; The International Federation of Clinical Chemistry and Laboratory Medicine, IFCC, Milan, Italy. Etienne.cavalier@chuliege.be ; The International Osteoporosis Foundation, IOF, Nyon, Switzerland. Etienne.cavalier@chuliege.be
Language :
English
Title :
Role of the Clinical Laboratory in the Assessment of Metabolic Musculoskeletal Diseases.
Vasikaran S, Eastell R, Bruyère O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420. 10.1007/s00198-010-1501-1 DOI: 10.1007/s00198-010-1501-1
Vasikaran S, Cooper C, Eastell R et al (2011) International osteoporosis foundation and international federation of clinical chemistry and laboratory medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 49:1271–1274. 10.1515/CCLM.2011.602 DOI: 10.1515/CCLM.2011.602
Morris HA, Eastell R, Jorgensen NR et al (2017) Clinical usefulness of bone turnover marker concentrations in osteoporosis. Clin Chim Acta 467:34–41 DOI: 10.1016/j.cca.2016.06.036
Cavalier E, Eastell R, Jørgensen NR et al (2019) A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (P1NP): a report from the IFCC-IOF joint committee for bone metabolism. Clin Chem Lab Med 25:1546–1555 DOI: 10.1515/cclm-2019-0174
Vasikaran SD, Bhattoa HP, Eastell R et al (2020) Harmonization of commercial assays for PINP; the way forward. Osteoporos Int. 10.1007/s00198-020-05310-6 DOI: 10.1007/s00198-020-05310-6
Cavalier E, Lukas P, Bottani M et al (2020) European biological variation study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM working group on biological variation and the international osteoporosis foundation-international federation of clinical chemistry committee on bone metabolism. Osteoporos Int. 10.1007/s00198-020-05362-8
Bhattoa HP, Cavalier E, Eastell R et al (2021) Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and beta-CTX in blood. Clin Chim Acta 515:16–20. 10.1016/j.cca.2020.12.023 DOI: 10.1016/j.cca.2020.12.023
Cavalier E, Eastell R, Jørgensen NR et al (2021) A multicenter study to evaluate harmonization of assays for C-Terminal telopeptides of type I collagen (ß-CTX): a report from the IFCC-IOF committee for bone metabolism (C-BM). Calcif Tissue Int 108:785–797 DOI: 10.1007/s00223-021-00816-5
Diemar SS, Dahl SS, West AS et al (2022) A systematic review of the circadian rhythm of bone markers in blood. Calcif Tissue Int. 10.1007/s00223-022-00965-1 DOI: 10.1007/s00223-022-00965-1
Vasikaran SD, Miura M, Pikner R et al (2021) Practical considerations for the clinical application of bone turnover markers in osteoporosis. Calcif Tissue Int. 10.1007/s00223-021-00930-4 DOI: 10.1007/s00223-021-00930-4
Cavalier E, Huyghebaert L, Rousselle O et al (2019) Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects. Clin Chem Lab Med 58:197–201. 10.1515/cclm-2019-0996 DOI: 10.1515/cclm-2019-0996
Alonso N, Zelzer S, Eibinger G, Herrmann M (2022) Vitamin D metabolites: analytical challenges and clinical relevance. Calcif Tissue Int. 10.1007/s00223-022-00961-5 DOI: 10.1007/s00223-022-00961-5
Alonso N, Meinitzer A, Fritz-Petrin E et al (2022) Role of vitamin K in bone and muscle metabolism. Calcif Tissue Int. 10.1007/s00223-022-00955-3 DOI: 10.1007/s00223-022-00955-3
Ladang A, Beaudart C, Reginster J-Y, et al (2022) Biochemical markers of musculoskeletal health and aging to be assessed in clinical trials of drugs aiming at the treatment of sarcopenia. Calcif Tissue Int. 10.1007/s00223-022-01054-z DOI: 10.1007/s00223-022-01054-z
Ladang A, Rauch F, Delvin E, Cavalier E (2022) Bone turnover markers in children: from laboratory challenges to clinical interpretation. Calcif Tissue Int. 10.1007/s00223-022-00964-2 DOI: 10.1007/s00223-022-00964-2
Makris K, Mousa C, Cavalier E (2022) Alkaline phosphatases: biochemistry, functions and measurement. Calcif Tissue Int. 10.1007/s00223-022-01048-x DOI: 10.1007/s00223-022-01048-x
Dincel AS, Jørgensen NR (2022) New emerging biomarkers for bone disease: sclerostin and Dickkopf-1 (DKK1). Calcif Tissue Int. 10.1007/s00223-022-01020-9 DOI: 10.1007/s00223-022-01020-9
Heijboer AC, Cavalier E (2022) The measurement and interpretation of fibroblast growth factor 23 (FGF23) concentrations. Calcif Tissue Int. 10.1007/s00223-022-00987-9 DOI: 10.1007/s00223-022-00987-9
Lombardi G, Delvin E (2022) Micro-RNA: A future approach to personalized diagnosis of bone diseases. Calcif Tissue Int. 10.1007/s00223-022-00959-z DOI: 10.1007/s00223-022-00959-z
